Law FirmOpposition Filing Analysis

The comprehensive analysis of Elkington And Fife opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Elkington And Fife

Patent NumberTitleApplicantOpposition DateOpposition Company
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 1, 2025GENERICS UK
Glycine For Use In Tolerance Induction In Allergic PatientsNUTRICIAJun 19, 2025SOCIETE DES PRODUITS NESTLE
Enantiomers Of Tetrahydro-N,N-Dimethyl-2,2-Diphenyl-3-Furanmethanamine (Anavex2-73) And Use Thereof In The Treatment Of Alzheimer'S Disease And Other Disorders Modulated By The Sigma 1 ReceptorANAVEX LIFE SCIENCESJun 12, 2025ELKINGTON AND FIFE
Capsule FormulationsCHEMOCENTRYXJun 12, 2025LEK PHARMACEUTICALS DD
Coffee Replicas Produced From Individual ComponentsAVA FOOD LABSJun 11, 2025SOCIETE DES PRODUITS NESTLE
Methods For Enhancing The Quality Of Life Of A Senior AnimalHILLS PET NUTRITIONJun 5, 2025SOCIETE DES PRODUITS NESTLE
High Caloric, High Protein Nutritional FormulaFRESENIUS KABI DEUTSCHLANDJun 5, 2025SOCIETE DES PRODUITS NESTLE
Methods Of Treating Pulmonary Arterial HypertensionACTELION PHARMACEUTICALSJun 4, 2025GENERICS UK
Aprocitentan For Use In The Treatment Of Hypertension And Related Diseases In Combination With Angiotensin Converting Enzyme Inhibitor (Ace) Or Angiotensin Receptor Blocker (Arb)IDORSIA PHARMACEUTICALSMay 29, 2025ELKINGTON AND FIFE
Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin TherapyAMARIN PHARMACEUTICALS IRELANDMay 9, 2025ELKINGTON AND FIFE